We are live on ! Find out more
ANAC

ANACOR PHARMACEUTICALS INC COM
ANAC

Delisted

ANAC was delisted on the 23rd of June, 2016.

Back to rankings

177 hedge funds and large institutions have $2.92B invested in ANACOR PHARMACEUTICALS INC COM in 2015 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 67 increasing their positions, 59 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

421% more call options, than puts

Call options by funds: $165M | Put options by funds: $31.7M

105% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 20

29% more capital invested

Capital invested by funds: $2.27B → $2.92B (+$653M)

14% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 59

13% more funds holding

Funds holding: 157 → 177 (+20)

0% more funds holding in top 10

Funds holding in top 10: 7 → 7 (0)

Holders
177
Holders Change
+20
Holders Change %
+12.74%
% of All Funds
4.77%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.19%
New
41
Increased
67
Reduced
59
Closed
20
Calls
$165M
Puts
$31.7M
Net Calls
+$133M
Net Calls Change
+$91.7M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$79.4M
2
JHIU
Janus Henderson Investors US
Colorado
+$77.8M
3
Invesco
Invesco
Georgia
+$14.2M
4
NCGI
Next Century Growth Investors
Minnesota
+$13.6M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$10.7M

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$48M
2
BBA
Baker Bros. Advisors
New York
-$38M
3
KCM
Kingdon Capital Management
New York
-$29.6M
4
FCM
Farallon Capital Management
California
-$26.2M
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$22M
Name Holding Trade Value Shares
Change 		Change in
Stake
ARC
126
Absolute Return Capital
Massachusetts
$482K +$408K +6,222 New
Simplex Trading
127
Simplex Trading
Illinois
$481K +$408K +6,216 New
FANJ
128
Financial Architects (New Jersey)
New Jersey
$465K – – –
Legal & General Group
129
Legal & General Group
United Kingdom
$448K +$49.8K +759 +15%
Balyasny Asset Management
130
Balyasny Asset Management
Illinois
$409K +$346K +5,280 New
BCM
131
Bluefin Capital Management
New York
$407K +$344K +5,250 New
HCMT
132
Highland Capital Management (Tennessee)
Tennessee
$387K – – –
CEP
133
Chicago Equity Partners
Illinois
$384K +$1.97K +30 +0.6%
CI
134
Cowen Inc
New York
$374K – – –
Canada Life
135
Canada Life
Manitoba, Canada
$365K – – –
CCMH
136
Cornerstone Capital Management Holdings
New York
$364K +$157K +2,400 +104%
VKH
137
Virtu KCG Holdings
New York
$363K +$308K +4,691 New
PIM
138
Provident Investment Management
Michigan
$348K -$78.7K -1,200 -21%
AB
139
Amalgamated Bank
New York
$328K +$278K +4,240 New
AG
140
Aperio Group
California
$321K +$26.8K +408 +11%
AP
141
AHL Partners
United Kingdom
$316K -$574K -8,754 -68%
LTFS
142
Ladenburg Thalmann Financial Services
Florida
$314K +$35.9K +548 +16%
HSBC Holdings
143
HSBC Holdings
United Kingdom
$287K +$243K +3,701 New
Capital Fund Management (CFM)
144
Capital Fund Management (CFM)
France
$271K +$229K +3,500 New
Mackenzie Financial
145
Mackenzie Financial
Ontario, Canada
$250K +$211K +3,223 New
AIP
146
Ameritas Investment Partners
Nebraska
$245K +$207K +3,163 New
BAAM
147
Baker Avenue Asset Management
California
$238K -$85.2K -1,300 -30%
M&T Bank
148
M&T Bank
New York
$236K +$200K +3,054 New
Parallax Volatility Advisers
149
Parallax Volatility Advisers
California
$232K +$196K +2,992 New
Barclays
150
Barclays
United Kingdom
$223K -$930K -14,187 -83%
4 5
6
7 8

ANAC Hedge Fund Activity: Q2 2015 in Review

177 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q2 2015, worth a combined $2.92B — up 29% from $2.27B a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new ANAC positions and 20 closed out — a net gain of 21 holders — while 67 added to existing stakes and 59 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $79.4M. The largest seller was Consonance Capital Management, exiting entirely with an estimated $48M sold.

  • 177 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q2 2015, up from 157 in Q1 2015.
  • Funds reported $2.92B of ANACOR PHARMACEUTICALS INC COM stock for Q2 2015, up 29% quarter-over-quarter.
  • 41 funds opened new ANACOR PHARMACEUTICALS INC COM positions in Q2 2015 and 20 closed out, a net change of +21 holders.
  • The largest ANACOR PHARMACEUTICALS INC COM buyer in Q2 2015 was Fidelity Investments, an estimated $79.4M added.
  • The largest ANACOR PHARMACEUTICALS INC COM seller in Q2 2015 was Consonance Capital Management, an estimated $48M sold.

Based on aggregated 13F filings for Q2 2015.